Loading clinical trials...
Loading clinical trials...
Impact of Nitazoxanide on Virologic Responses in Chronic HCV Infected Patients With Genotype 4: A Placebo-controlled Randomized Trial
Conditions
Interventions
Placebo
Nitazoxanide
Locations
1
Egypt
National Liver Institute
Shebin El-Kom, Monufia Governorate, Egypt
Start Date
September 1, 2010
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
September 30, 2014
NCT06953479
NCT03135886
NCT05968573
NCT05042544
NCT05870969
NCT05361603
Lead Sponsor
National Liver Institute, Egypt
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions